Here’s How Intrexon Might Prove Me Wrong – nwitimes.com
nwitimes.com |
Here’s How Intrexon Might Prove Me Wrong
nwitimes.com Synthetic biology toolkit: One of the most difficult things about developing the technology platform is figuring out how to work with gas fermentation at the lab scale. Intrexon spent a lot of time developing completely new equipment to accomplish this … |
The Sun |
11 Organizations Urge Caution, Not Ban, on CRISPR Germline Genome Editing
Genetic Engineering & Biotechnology News (press release) One day after publication of a landmark study detailing the first-in-the-U.S. use of CRISPR to repair a germline mutation in human embryos created through in vitro fertilization, 11 genetics-focused professional organizations are calling for … What is CRISPR-Cas9, how does gene editing work, who discovered the technique and could it mean we live longer?The Sun Understanding how CRISPR works: The basicsGenetic Literacy Project CRISPR Used to Correct Pathogenic Gene Mutation in Human EmbryosTechnology Networks Science News Magazine –iGyaan Network (blog) –New York Times all 49 news articles » |
Multiple Sclerosis News Today |
A Warning About ‘Stem Cell Tourism’
Multiple Sclerosis News Today I regularly see comments on various social media sites from MS patients who have traveled, or who plan to travel, outside the U.S. to be treated with stem cells. Some of these patients have reported excellent results and a reversal of symptoms. Others … |
Multiple Sclerosis News Today |
A Warning About ‘Stem Cell Tourism’
Multiple Sclerosis News Today I regularly see comments on various social media sites from MS patients who have traveled, or who plan to travel, outside the U.S. to be treated with stem cells. Some of these patients have reported excellent results and a reversal of symptoms. Others … |
|
ctDNA as a Blood-based Biomarker for Immunotherapy Response
Technology Networks Immunotherapy is giving patients with metastasized NSCLC a second chance at finding the right treatment for them. In fact, with new immunomodulatory drugs like the PD-1 inhibitors pembrolizumab and nivolumab, we’ve seen patients exhibit durable … |
|
ctDNA as a Blood-based Biomarker for Immunotherapy Response
Technology Networks Immunotherapy is giving patients with metastasized NSCLC a second chance at finding the right treatment for them. In fact, with new immunomodulatory drugs like the PD-1 inhibitors pembrolizumab and nivolumab, we’ve seen patients exhibit durable … |
The Scientist |
Skin Graft-based Gene Therapy Treats Diabetes in Mice
The Scientist skin graft An immunofluorescence image of one of the engineered skin graftsXIAOYANG WU ET AL.In a proof of concept study, researchers have used a gene-edited skin graft to treat diabetes in mice, they reported yesterday (August 3) in Cell Stem Cell. Gene therapy via skin could treat many diseases, even obesityScience Daily CRISPR Gene Therapy via Skin Grafts Treats Obesity and Diabetes in MiceGenetic Engineering & Biotechnology News This new gene therapy via skin can help treat diabetes, obesityZee News ResearchGate (blog) –CNBC –New Atlas all 18 news articles » |